Close Menu
Home › Cepheid Wins FDA Approval for Xpress Flu, Flu/RSV Tests

Cepheid Wins FDA Approval for Xpress Flu, Flu/RSV Tests

Feb 15, 2017

NEW YORK (GenomeWeb) – Cepheid's Xpert Xpress Flu and Xpert Xpress Flu/RSV tests have received clearance from the US Food and Drug Administration, the firm announced today.

The tests are the first in the firm's planned line of Xpress branded tests — faster versions of the firm's Xpert test cartridges enabling test times of 30 minutes or less.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In PCR

  1. T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

  2. Genedrive Receives CE Mark for Hearing Loss Assay

  3. Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.